A Canadian trial including 120 subjects is investigating the safety and efficacy of an acrylic, foldable, single-piece, angle-supported phakic IOL (AcrySof Cachet, Alcon).
Ocuphire Pharma submits New Drug Application to FDA for Nyxol eye drops for reversal of mydriasis
New potential mechanism for vision loss discovered
Retinal cells may have potential to protect themselves from diabetic retinopathy
